Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Dermatol Online J ; 17(11): 2, 2011 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-22136858

RESUMEN

In addition to the well-known signs of methotrexate toxicity, rare cutaneous side effects have been described. These cutaneous signs may provide a diagnostic clue into the diagnosis of toxicity as well as facilitate early and aggressive therapy. We describe the case of a 37-year-old male, with a diagnosis of psoriasis, who developed characteristic signs and symptoms of acute methotrexate toxicity after receiving an unknown amount of intravenous methotrexate. The patient experienced a distinct change in the morphology of his existing psoriatic plaques, which became ulcerated and necrotic in the week following the methotrexate injection. Shortly after the development of cutaneous erosions, the patient developed pancytopenia, which ultimately led to his death. Ulceration and necrosis of cutaneous psoriasis plaques may serve as a herald for the impending development of life-threatening pancytopenia in patients with acute methotrexate toxicity.


Asunto(s)
Inmunosupresores/efectos adversos , Metotrexato/efectos adversos , Psoriasis/patología , Úlcera Cutánea/inducido químicamente , Lesión Renal Aguda/inducido químicamente , Adulto , Azitromicina/uso terapéutico , Biopsia , Resultado Fatal , Filgrastim , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Leucovorina/uso terapéutico , Masculino , Metotrexato/uso terapéutico , Mucositis/inducido químicamente , Necrosis , Pancitopenia/inducido químicamente , Plasma , Psoriasis/tratamiento farmacológico , Proteínas Recombinantes/uso terapéutico , Automedicación , Úlcera Cutánea/etiología , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA